News

At Dell Laser Consultants we have the highest commitment not only to bring you the best technology in the world, but also continue to serve as experts in this technology.  We often look outside ophthalmology to gain a comprehensive understanding of these technologies.  This perspective allows us to be leaders in surgical innovations. 

Here is a recent visit by Dr. Dell to the W.M. Keck Observatory.  This is the world’s most powerful telescope.  It uses adaptive optics (the same technology used by our LASIK laser) to produce images that are more detailed than even the Hubble Space telescope.

Dell Laser Consultants begins study on corneal nerve regeneration after LASIK surgery.  DLC will be part of a large multi-center randomized double blind study to assess the effect of Restasis ophthalmic solution on corneal nerve regeneration.  This study may have implications far beyond LASIK including corneal disease treatments and other surgeries. 

Restasis is commonly used after LASIK surgery to decrease dry eye symptoms.  Some scientists believe that it may additionally increase corneal nerve regeneration.  This study aims to add some clarity to this speculation.

If you are thinking about having LASIK surgery in Austin, TX, and would like to learn more about this study please contact Dell Laser Consultants at 512-347-0255.  Study participants will be financially compensated.   

More Americans have myopia now than in the ’70s, study finds

TUESDAY, Dec. 15 (HealthDay News) — Myopia (nearsightedness) is more common in the United States than it was more than 30 years ago, a National Eye Institute study shows.

Researchers compared National Health and Nutrition Examination Survey data from 4,436 black and white participants from 1971 to 1972 and from 8,339 black and white participants from 1999 to 2004. The participants were 12 to 54 years old.

The prevalence of myopia increased from 25 percent in 1971-1972 to 41.6 percent in the later period. The incidence jumped from 13 percent to 33.5 percent among blacks, and 26.3 percent to 43 percent among whites.

The findings appear in the December issue of the Archives of Ophthalmology.

Even though myopia can be treated with eyeglasses, contact lenses or refractive surgery (LASIK), its high prevalence costs Americans billions of dollars a year, the researchers noted.

“The question of whether myopia prevalence is increasing is therefore important to health planners and policy makers,” the study authors concluded. “Identifying modifiable risk factors for the development of myopia could lead to the development of cost-effective interventional strategies.”

Taken from http://www.businessweek.com/lifestyle/content/healthday/634053.html

0% interest financing for 18 month is now available.  Most patients qualify, and this lets you make payments into 2011without paying interest.  There has never been a better time to have LASIK or refractive surgery in Austin.   

This offer will be available through December 2009.

Dr. Dell recently chaired the 2009 Advanced Refractive IOL Symposium.  This meeting involved some of the most respected refractive surgeons in the country.  Dr. Dell moderated discussions of advanced techniques dealing with LASIK and cataract refractive surgery.  This meeting is widely regarded as on of the best opportunities for the nation’s top refractive surgeons to get together and discuss advanced surgical techniques and develop cutting edge research. 

Dr. Dell was the only LASIK or cataract surgeon from Austin, Texas to be invited to the meeting.  

This award recognizes surgeons that have significant contributions to the Academy through academic and educational activities.

Brendan Hansen (holding his Beijing Olympic Gold Medal) and Dr. Derek N. Cunningham in front of the Visx4 Star IR laser - Austin

Brendan Hansen recently chose Dell Laser Consultants for LASIK on his own eyes. Weeks after his surgery, he stated that it was one of the best things he has ever done.

Professional athletes, pilots and eye doctors choose Dr. Dell for their own eyes. Patients whose livelihood depends on exceptional vision seek out Dr. Dell for his reputation as one of the best refractive surgeons in the country coupled with his incredible attention to detail. We feel that everyone deserves this type of treatment and encourage all patients book a consult with Dell Laser Consultants.

Dr. Dell named by his worldwide peers as one of the Top Fifty Opinion Leaders in the field of Cataract and Refractive Surgery for the Second Year in a Row.

Dell Laser Consultants is very proud to announce that on March 18th, 2006 at an award ceremony in San Francisco, Dr. Steven J. Dell was elected one of the Top Fifty Opinion Leaders in the Field of Cataract and Refractive Surgery by the worldwide physician readership of the medical journal “Cataract and Refractive Surgery Today“. This is the second year in a row that Dr. Dell has won the award, which honors a prestigious group of world leaders in the field. Dr. Dell is one of the youngest physicians to receive this award, which recognizes excellence in innovative surgical techniques, surgical research and technology, clinical teaching, and a positive impact of the careers of the voting physicians.

Dell Laser Consultants announces Dr. Steven Dell named a “Super Doctor” by Texas Monthly Magazine for the 3rd straight year.

Dell Laser Consultants is proud to announce that our Medical Director Dr. Steven J. Dell has been named a “Super Doctor” by Texas Monthly Magazine for the third year in a row. This honor is the result of a 2007 poll of over 37,000 Texas doctors. The poll asked the respondents to select the doctor to whom they would send a loved one or one of their patients. Winners were announced in 29 categories. The poll was conducted by Key Professional Media, and will be announced in the December 2007 issue of Texas Monthly Magazine.

Dell Laser Consultants Launches Two New FDA Clinical Trials for LASIK

Dell Laser Consultants is pleased to announce that it has initiated several FDA clinical trials testing investigational excimer lasers for LASIK, as well as pharmaceuticals. Very few sites in the US are selected to perform these studies, which will be closely watched by surgeons around the world. Participation in the clinical trials is strictly voluntary, and a limited number of patients can be treated under the FDA protocols. All participants in the trials will be notified that they are participating in a formal FDA clinical trial, and will be offered treatment with another FDA approved laser if they prefer. As compensation for participation in one of these FDA trials, patients will have the majority of their surgical fee waived. If you are interested in volunteering for one of these clinical trials, please feel free to contact us at 512-347-0255 and mention the “FDA Trial.”

For more information on LASIK visit the FDA website at: www.fda.gov/cdrh/lasik/